The Company’s Compensation Committee consists of three members appointed by the Board of Directors, with a majority being independent directors. The Committee meets at least twice a year to objectively evaluate compensation policies and systems for directors and managerial officers, and submits its recommendations to the Board for discussion.
The duties and rights of the Compensation Committee are as follows:
Members
| Title | Name | Current Position | Education (Experience) | 
|---|---|---|---|
| 
													Independent Director (Convener) | Tsai-Chen Hsu | 
													Independent Director, Azion Corporation												 | Ph.D. in Economics, Nankai University | 
| 
													Independent Director												 | 
													Jeng-Chun, Chen												 | 
													Director, CDIB Capital Innovation Accelerator Co., Ltd.												 | EMBA, National Taiwan University | 
| 
													Independent Director												 | 
													Yu-Min Yang												 | 
													Independent Director, Lotus Pharmaceutical Co., Ltd.												 | Accounting and Management Decision Group, EMBA, National Taiwan University | 
2024 Operation of the Compensation Committee
| Title | Name | Attendance in Person | By Proxy | Attendance Rate in Person (%) | 
|---|---|---|---|---|
| 
													Independent Director
(Convener)												 | 
													Tsai-Chen Hsu												 | 
													6												 | 0 | 
													100%												 | 
| 
													Independent Director												 | 
													Jeng-Chun, Chen												 | 
													6												 | 0 | 
													100%												 | 
| 
													Independent Director												 | 
													Yu-Min Yang												 | 
													6												 | 0 | 100% | 
